[SCAN] Plant biofactories for the production of high value molecules

Title: Plant biofactories for the production of high value molecules

Speaker: Rita Abranches 

Abstract: It has been 30 years since the pioneering work of Hiatt and colleagues made the cover of Nature with the report of the first successful expression of recombinant antibodies in plants. Since then, Plant Molecular Farming has made great progress through years of steady >activity. In 2012, when the first plant-made biopharmaceutical was approved for market release, the production of recombinant proteins in plant-based systems became a reality. In 2022, the first vaccine for humans produced in plants was approved in Canada for protection against Covid-19. I will give an overview of the fascinating world of Molecular Farming and talk about two ongoing projects in our laboratory, which include not only the production of recombinant proteins but also of small molecules with important bioactivities. This talk will highlight the versatility of plant-based platforms for the production of recombinant proteins and other high-value compounds.